Colgate-PalmoliveCoca-Cola Europacific Partners

Colgate-Palmolive vs Coca-Cola Europacific Partners

Global oral care and household products leader vs Major Coca-Cola bottler across Europe and Asia-Pacific. Which is the better buy for your portfolio in June 2026? Plain-English answer below.

Colgate-Palmolive vs Coca-Cola Europacific Partners sets a household staples giant against a major bottling and distribution powerhouse, two companies that depend on massive operational scale and deep...

Why It’s Moving

Colgate-Palmolive

Colgate-Palmolive faces fresh analyst pressure as margin worries keep the stock under strain.

  • TD Cowen cut Colgate-Palmolive to Hold from Buy, citing heightened inflationary pressure and weaker room for margin expansion.
  • Argus also downgraded the stock to Hold, highlighting margin pressure and a minimal growth outlook that could limit upside.
  • Stifel reduced its rating to Hold and trimmed its price target, reinforcing the view that the shares are being capped by valuation concerns and slower earnings momentum.
Sentiment:
🐻Bearish
Coca-Cola Europacific Partners

CCEP slips as analysts turn more cautious after a strong run and softer near-term visibility.

  • Morgan Stanley cut CCEP from Overweight to Equal-weight, signaling that recent gains may have already captured much of the good news.
  • Analysts pointed to a more balanced risk-reward setup, suggesting the stock’s valuation has caught up with its recent performance.
  • Short-term revenue visibility has softened, which can weigh on sentiment even when the underlying business remains stable.
Sentiment:
🐻Bearish

Investment Analysis

Pros

  • Colgate-Palmolive achieved organic sales growth of 2.4% in Q2 2025, demonstrating resilience despite inflation and foreign exchange headwinds.
  • The company maintains a strong global market position in household and personal care products, supported by high gross profit margins of over 60%.
  • Colgate-Palmolive offers a stable dividend yield of around 2.7%, appealing to income-focused investors seeking consistent returns.

Considerations

  • The stock trades at a premium valuation, with a P/E ratio above sector average, which may limit upside for new investors.
  • Recent analyst price targets have been lowered, reflecting concerns about future growth and limited share price appreciation over the past year.
  • Colgate-Palmolive faces ongoing exposure to raw material cost pressures and currency volatility, which could impact profitability.

Pros

  • Coca-Cola Europacific Partners benefits from strong brand recognition and a dominant position in the European and Pacific beverage markets.
  • The company has demonstrated consistent revenue growth, supported by a diversified product portfolio and strategic distribution networks.
  • It maintains healthy operating margins and a solid return on equity, reflecting efficient capital allocation and operational discipline.

Considerations

  • The business is exposed to regulatory risks and changing consumer preferences, particularly around sugar content and health concerns.
  • Coca-Cola Europacific Partners faces competitive pressures from both global and local beverage brands, which could constrain pricing power.
  • The company's performance is sensitive to macroeconomic factors, including inflation and currency fluctuations, especially in its international markets.

Colgate-Palmolive (CL) Next Earnings Date

Colgate-Palmolive’s next earnings date for CL is expected to be July 31, 2026, before the market opens. The report should cover Q2 2026 results. This timing is consistent with the company’s usual late-July earnings pattern.

Coca-Cola Europacific Partners (CCEP) Next Earnings Date

The next earnings date for CCEP is August 4, 2026. Based on the company’s reporting cadence, that release should cover second-quarter 2026 results. Some calendars show a broader window around early August, but August 4, 2026 is the clearest current estimate.

Buy CL or CCEP in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

CL
CL$89.47
vs
CCEP
CCEP$96.93
Buy CL